Ubp Investment Advisors Sa Eli Lilly & CO Transaction History

Ubp Investment Advisors Sa

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $2.68 Million - $3.15 Million	-9,632 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $1.79 Million - $2.23 Million	7,632 Added 381.6%	9,632 $270,000
Q4 2020 Feb 23, 2021	SELL	$130.46 - $172.63 $39,138 - $51,789	-300 Reduced 13.04%	2,000 $338,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $39,138 - $51,789	300 Added 15.0%	2,300 $388,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $238,100 - $294,700	2,000 New	2,000 $277,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Ubp Investment Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Ubp Investment Advisors Sa with notifications on news.